Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 20/20 | 0.68 |
| ▸ | CDK12 | Q9NYV4 | 20/20 | 0.68 |
| ▸ | CCNT1 | O60563 | 17/20 | 0.68 |
| ▸ | CDK9 | P50750 | 17/20 | 0.68 |
| ▸ | CCNE1 | P24864 | 16/20 | 0.68 |
| ▸ | CDK2 | P24941 | 16/20 | 0.68 |
| ▸ | CDK7 | P50613 | 9/20 | 0.66 |
| ▸ | CCNH | P51946 | 9/20 | 0.66 |
| ▸ | MNAT1 | P51948 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL26628934 | 0.96 | CCNK (0.64) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24583196 | 0.95 | CCNK (0.70) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL26628943 | 0.95 | CCNK (0.70) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL29283731 | 0.91 | CCNK (0.75) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL29283735 | 0.91 | CCNK (0.75) | CCNKCDK12CCNT1CDK9CCNE1 | |
| Formic Acid SCHEMBL30549102 | 0.91 | CCNK (0.65) | CCNKCDK12CCNT1CDK9CCNE1 | |
| Formic Acid SCHEMBL26628916 | 0.91 | CCNK (0.65) | CCNKCDK12CCNT1CDK9CCNE1 | |
| Formic Acid SCHEMBL26628926 | 0.91 | CCNK (0.65) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL24583272 | 0.89 | CCNK (0.65) | CCNKCDK12CCNT1CDK9CCNE1 | |
| SCHEMBL26628917 | 0.86 | CCNK (0.69) | CCNKCDK12CCNT1CDK9CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4269402-A1 | AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | GT Apeiron Therapeutics Limited (HK) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022134641-A1 | AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 湃隆生物科技有限公司（香港） | 2022-06-30 | — | — | WO | disclosed |